Vericel Announces Publication of Positive Results from Phase 3 Debride and Protect (DETECT) ...

Data published in the Journal of Burn Care & Research show treatment with NexoBrid resulted in early complete eschar removal in more than 90% of treated patients, and reduced surgery

Related Keywords

United States ,Cambridge ,Cambridgeshire ,United Kingdom ,American ,Jon Hopper ,Eric Burns ,Pwww Nexobrid ,Mediwound Ltd ,Exchange Commission ,Journal Of Burn Care Research ,Vericel Corporation ,Burn Care ,Gel Vehicle ,Chief Medical Officer ,North American ,Region ,